Document Type : Original Article
Authors
- . Rasool Nouri
- . Raheleh Salari 1
- . Sharareh R. Niakan Kalhori 2
- . Seyed Mohammad Ayyoubzadeh 3
- . Marsa Gholamzadeh 3
1 Department of Ophthalmology, Poostchi Ophthalmology Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
2 Research Fellow and Guest Scientists, Peter L. Reichertz Institute for Medical Informatics of TU Braunschweig and Hannover Medical School, Hannover, Germany Ph.D. in Medical Informatics, Associate Professor, Department of Health Information Management, School of Allied Medical Sciences, Tehran University of Medical Science, Tehran, Iran
3 Department of Health Information Management, School of Allied Medical Sciences, Tehran University of Medical Science, Tehran, Iran
Abstract
BACKGROUND: Since the beginning of the COVID‑19 outbreak, a significant number of mobile
health apps have been created around the world and in Iran to help consequence reduction of this
emerging pandemic.
OBJECTIVES: This study aimed to review the characteristics of Persian Android and iOS apps
related to COVID‑19 and determine their use‑cases based on a reference model.
METHODS: This was a cross‑sectional descriptive study conducted in three main steps. First, a
systematic search was conducted via Iranian mobile apps’ markets using the keywords related to
COVID‑19 in January 2021. Then, the retrieved apps were analyzed according to their characteristics.
Finally, the use‑cases of the given apps were determined and categorized based on a reference model.
RESULTS: Based on our inclusion criteria, 122 apps were selected and evaluated. Most of these
apps (87.7%) was free. Small proportions (5%) of reviewed apps have been developed with
participation of clinical expert and half of the apps mentioned the references they used. Furthermore,
about half of the apps (50.8%) were provided contact information of the developers. The studied
apps were classified into four use‑case major categories, including educational (98%), fulfilling a
contextual need (18%), communicating, and/or sharing the information (0.83%), and health‑related
management (2%).
CONCLUSION: The results showed that the Persian mobile apps for COVID‑19 are not in a satisfying
situation. Furthermore, although these apps are significant in quantity but in terms of use‑cases,
they are not widespread.
Keywords
et al. Mortality risk factors among hospitalized COVID‑19 patients
in a major referral center in Iran. Tohoku J Exp Med 2020;252:73‑84.
2. Worldometers. Reported Cases and Deaths by Country, Territory,
or Conveyance; 2021. Availble from: https://www.worldometers.
info/coronavirus/. [Last Accessed on 05 Jan 2022].
3. Aslani N, Lazem M, Mahdavi S, Garavand A. A review of mobile
health applications in epidemic and pandemic outbreaks: Lessons
learned for COVID‑19. Arch Clin Infect Dis 2020;15:1‑7.
4. Nouri R, R Niakan Kalhori S, Ghazisaeedi M, Marchand G,
Yasini M. Criteria for assessing the quality of mHealth apps:
A systematic review. J Am Med Inform Assoc 2018;25:1089‑98.
5. Mohanty B, Chughtai A, Rabhi F. Use of Mobile Apps for epidemic
surveillance and response‑availability and gaps. Glob Biosecur
2019 Sep 11;1(1).
6. John Leon Singh H, Couch D, Yap K. Mobile health apps that
help with COVID‑19 management: Scoping review. JMIR Nurs
2020;3:e20596.
7. Yasini M, Marchand G. Toward a use case based classification
of mobile health applications. Stud Health Technol Inform
2015;210:175‑9.
8. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred
reporting items for systematic reviews and meta‑analyses: The
PRISMA statement. PLoS Med 2009;6:e1000097.
9. Larsen ME, Nicholas J, Christensen H. Quantifying App Store
Dynamics: Longitudinal Tracking of Mental Health Apps. JMIR
Mhealth Uhealth. 2016;4(3):e96.
10. Hussain M, Al-Haiqi A, Zaidan AA, Zaidan BB, Kiah M, Iqbal S, et
al. A security framework for mHealth apps on Android platform.
Computers & Security. 2018;75:191-217.
11. Fougerouse P-A, Yasini M, Marchand G, Aalami OO. A CrossSectional Study of Prominent US Mobile Health Applications:
Evaluating the Current Landscape. AMIA Annu Symp Proc.
2018;2017:715-23.
12. Wyatt JC. How can clinicians, specialty societies and others
evaluate and improve the quality of apps for patient use? BMC
Medicine. 2018;16(1):225.
13. Saeedi MG, Kalhori SR, Nouri R, Yasini M. Persian mHealth Apps:
A Cross Sectional Study Based on Use Case Classification. Studies
in health technology and informatics. 2016;228:230-4.
14. Salehinejad S, Niakan Kalhori SR, Hajesmaeel Gohari S,
Bahaadinbeigy K, Fatehi F. A review and content analysis
of national apps for COVID-19 management using Mobile
Application Rating Scale (MARS). Informatics for Health and
Social Care. 2021;46(1):42-55.
15. Davalbhakta S, Advani S, Kumar S, Agarwal V, Bhoyar S,
Fedirko E, et al. A Systematic Review of Smartphone Applications
Available for Corona Virus Disease 2019 (COVID19) and the
Assessment of their Quality Using the Mobile Application Rating
Scale (MARS). J Med Syst. 2020;44(9):164-.
16. Alanzi T. A Review of Mobile Applications Available in the App
and Google Play Stores Used During the COVID-19 Outbreak.
Journal of multidisciplinary healthcare. 2021;14:45-57.
17. Anglemyer A, Moore TH, Parker L, Chambers T, Grady A,
Chiu K, et al. Digital contact tracing technologies in epidemics:
a rapid review. The Cochrane database of systematic reviews.
2020;8:Cd013699.
18. Reddy BV, Gupta A. Importance of effective communication
during COVID-19 infodemic. Journal of Family Medicine and
Primary Care. 2020;9(8):3793.
19. Bassi A, Arfin S, John O, Jha V. An overview of mobile applications
(apps) to support the coronavirus disease 2019 response in India.
The Indian journal of medical research. 2020;151(5):468-73.
20. Gong M, Liu L, Sun X, Yang Y, Wang S, Zhu H. Cloud-Based
System for Effective Surveillance and Control of COVID-19:
Useful Experiences From Hubei, China. Journal of medical
Internet research. 2020;22(4):e18948.
21. Lai SHS, Tang CQY, Kurup A, Thevendran G. The experience
of contact tracing in Singapore in the control of COVID-19:
highlighting the use of digital technology. International
orthopaedics. 2021;45(1):65-9.
22. Wong CK, Ho DT, Tam AR, Zhou M, Lau YM, Tang MO, et al.
Artificial intelligence mobile health platform for early detection
of COVID-19 in quarantine subjects using a wearable biosensor:
protocol for a randomised controlled trial. BMJ open. 2020 Jul
1;10(7):e038555.
23. Kalhori SRN, Bahaadinbeigy K, Deldar K, Gholamzadeh M,
Hajesmaeel-Gohari S, Ayyoubzadeh SM. Digital health solutions
to control the COVID-19 pandemic in countries with high disease
prevalence: Literature review. Journal of medical Internet
research. 2021;23(3):e19473.
)